FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045367162> ?p ?o ?g. }

• W2045367162 endingPage "364" @default.
• W2045367162 startingPage "356" @default.
• W2045367162 abstract "Adherence is a strong determinant of viral suppression with antiretroviral therapy (ART) but measuring it is challenging. Medication delivery can be measured accurately in settings with computerized prescription databases. We studied the association between medication possession ratio (MPR), virologic suppression, and resistance to ART in Côte d'Ivoire.We conducted a prospective cohort study of HIV-1-infected adults initiating ART in 3 clinics using computerized monitoring systems. Patients had viral load (VL) tests at month 6 (M6) and month 12 (M12) after ART initiation and genotype tests if VL was detectable (≥300 copies/mL). MPR was defined as the number of daily doses of antiretroviral drug actually provided divided by the total number of follow-up days since ART initiation.Overall, 1573 patients started ART with stavudine/zidovudine plus lamivudine plus nevirapine/efavirenz. At M6 and M12, 996 and 942 patients were in active follow-up; 20% (M6) and 25% (M12) of patients had detectable VL, including 7% (M6) and 11% (M12) with ≥1 resistance mutation. Among patients with MPR of ≥95%, 80%-94%, 65%-79%, 50%-64%, and <50% at M12, the proportion with detectable VL [resistance] was 9% [4%], 17% [7%], 45% [24%], 67% [31%], and 85% [37%]. Among patients with ≥1 mutation at M12, 86% were resistant to lamivudine/emtricitabine and/or nevirapine/efavirenz but not to other drugs.MPR was strongly associated with virologic outcomes. Half of those with detectable VL at M12 had no resistance mutations. MPR should be used at M6 to identify patients who might benefit from early interventions to reinforce adherence." @default.
• W2045367162 created "2016-06-24" @default.
• W2045367162 creator A5003424194 @default.
• W2045367162 creator A5015116905 @default.
• W2045367162 creator A5019522183 @default.
• W2045367162 creator A5024120430 @default.
• W2045367162 creator A5027866615 @default.
• W2045367162 creator A5029835674 @default.
• W2045367162 creator A5049211238 @default.
• W2045367162 creator A5057579434 @default.
• W2045367162 creator A5063663542 @default.
• W2045367162 creator A5066083849 @default.
• W2045367162 creator A5072327252 @default.
• W2045367162 creator A5074313423 @default.
• W2045367162 date "2011-04-01" @default.
• W2045367162 modified "2023-09-26" @default.
• W2045367162 title "Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'Ivoire" @default.
• W2045367162 cites W1951712651 @default.
• W2045367162 cites W1964020548 @default.
• W2045367162 cites W1971334912 @default.
• W2045367162 cites W1973489201 @default.
• W2045367162 cites W1975850502 @default.
• W2045367162 cites W1980520085 @default.
• W2045367162 cites W1986667969 @default.
• W2045367162 cites W1998210875 @default.
• W2045367162 cites W2004152021 @default.
• W2045367162 cites W2006910736 @default.
• W2045367162 cites W2011608109 @default.
• W2045367162 cites W2020086850 @default.
• W2045367162 cites W2032240325 @default.
• W2045367162 cites W2032952072 @default.
• W2045367162 cites W2042085468 @default.
• W2045367162 cites W2047274488 @default.
• W2045367162 cites W2048383566 @default.
• W2045367162 cites W2054322922 @default.
• W2045367162 cites W2057112394 @default.
• W2045367162 cites W2058404981 @default.
• W2045367162 cites W2063611994 @default.
• W2045367162 cites W2064000153 @default.
• W2045367162 cites W2064871165 @default.
• W2045367162 cites W2065654485 @default.
• W2045367162 cites W2077020785 @default.
• W2045367162 cites W2078908246 @default.
• W2045367162 cites W2079201451 @default.
• W2045367162 cites W2085243794 @default.
• W2045367162 cites W2130715578 @default.
• W2045367162 cites W2140243859 @default.
• W2045367162 cites W2150340704 @default.
• W2045367162 cites W2170507689 @default.
• W2045367162 doi "https://doi.org/10.1097/qai.0b013e3182084b5a" @default.
• W2045367162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3050083" @default.
• W2045367162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21191309" @default.
• W2045367162 hasPublicationYear "2011" @default.
• W2045367162 type Work @default.
• W2045367162 sameAs 2045367162 @default.
• W2045367162 citedByCount "70" @default.
• W2045367162 countsByYear W20453671622012 @default.
• W2045367162 countsByYear W20453671622013 @default.
• W2045367162 countsByYear W20453671622014 @default.
• W2045367162 countsByYear W20453671622015 @default.
• W2045367162 countsByYear W20453671622016 @default.
• W2045367162 countsByYear W20453671622017 @default.
• W2045367162 countsByYear W20453671622018 @default.
• W2045367162 countsByYear W20453671622019 @default.
• W2045367162 countsByYear W20453671622020 @default.
• W2045367162 countsByYear W20453671622021 @default.
• W2045367162 countsByYear W20453671622022 @default.
• W2045367162 countsByYear W20453671622023 @default.
• W2045367162 crossrefType "journal-article" @default.
• W2045367162 hasAuthorship W2045367162A5003424194 @default.
• W2045367162 hasAuthorship W2045367162A5015116905 @default.
• W2045367162 hasAuthorship W2045367162A5019522183 @default.
• W2045367162 hasAuthorship W2045367162A5024120430 @default.
• W2045367162 hasAuthorship W2045367162A5027866615 @default.
• W2045367162 hasAuthorship W2045367162A5029835674 @default.
• W2045367162 hasAuthorship W2045367162A5049211238 @default.
• W2045367162 hasAuthorship W2045367162A5057579434 @default.
• W2045367162 hasAuthorship W2045367162A5063663542 @default.
• W2045367162 hasAuthorship W2045367162A5066083849 @default.
• W2045367162 hasAuthorship W2045367162A5072327252 @default.
• W2045367162 hasAuthorship W2045367162A5074313423 @default.
• W2045367162 hasBestOaLocation W20453671622 @default.
• W2045367162 hasConcept C104317684 @default.
• W2045367162 hasConcept C114851261 @default.
• W2045367162 hasConcept C126322002 @default.
• W2045367162 hasConcept C142462285 @default.
• W2045367162 hasConcept C156719811 @default.
• W2045367162 hasConcept C159047783 @default.
• W2045367162 hasConcept C182707283 @default.
• W2045367162 hasConcept C188816634 @default.
• W2045367162 hasConcept C2522874641 @default.
• W2045367162 hasConcept C2777869810 @default.
• W2045367162 hasConcept C2778451633 @default.
• W2045367162 hasConcept C2779130552 @default.
• W2045367162 hasConcept C2779465607 @default.
• W2045367162 hasConcept C2779778239 @default.
• W2045367162 hasConcept C2779889181 @default.
• W2045367162 hasConcept C2780216070 @default.

• next